Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Amag Pharmaceuticals (NQ: AMAG )

13.75 USD UNCHANGED
Last Price Updated: 4:06 PM EST, Nov 13, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Amag Pharmaceuticals

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
50 51 Next >
AMAG Pharmaceuticals Appoints Nancy Griffith, PH.D., as Vice President of Scientific Communications and Medical Operations
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of Nancy Griffith, Ph.D., as vice president, scientific communications and medical operations, reporting to Brian Robinson,... 
From GlobeNewswire News Releases
Amag Pharmaceuti Down 29.3% Since SmarTrend Downtrend Call (AMAG)
SmarTrend identified a Downtrend for Amag Pharmaceuti (NASDAQ:AMAG) on November 1st, 2018 at $17.89. In approximately 5 months, Amag Pharmaceuti has returned 29.35% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
AMAG Pharmaceuticals Appoints New Members to Board of Directors
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the election of two new members to its Board of Directors—Anne Phillips, M.D., senior vice president, clinical development, medical and... 
From GlobeNewswire News Releases
Analysts Forecast 11% Upside For IJR
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Market Trends Toward New Normal in PS Business Parks, New Senior Investment Group, Civeo, PCM, GAIN Capital, and AMAG Pharmaceuticals — Emerging Consolidated Expectations, Analyst Ratings
In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of PS Business Parks, Inc.... 
From GlobeNewswire News Releases
28.3% Return Seen to Date on SmarTrend Amag Pharmaceuti Call (AMAG)
SmarTrend identified a Downtrend for Amag Pharmaceuti (NASDAQ:AMAG) on November 1st, 2018 at $17.89. In approximately 5 months, Amag Pharmaceuti has returned 28.34% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
AMAG Pharmaceuticals to Present at Needham 18th Annual Healthcare Conference
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that Ted Myles, chief financial officer, will present at the Needham 18th Annual Healthcare Conference in New York City on Tuesday, April 9,... 
From GlobeNewswire News Releases
Amag Pharmaceuti Down 30.4% Since SmarTrend Downtrend Call (AMAG)
SmarTrend identified a Downtrend for Amag Pharmaceuti (NASDAQ:AMAG) on November 1st, 2018 at $17.89. In approximately 5 months, Amag Pharmaceuti has returned 30.35% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
March of Dimes and AMAG Pharmaceuticals, Inc., Announce First Joint Supportive Pregnancy Care Program
First Site Launches in Springfield, Mass. Offering an Innovative Model of Group Prenatal Care 
From GlobeNewswire News Releases
First Week of November 15th Options Trading For AMAG Pharmaceuticals (AMAG)
Investors in AMAG Pharmaceuticals, Inc. (AMAG) saw new options begin trading this week, for the November 15th expiration.. 
Tags Stocks
From Market News Video
Downtrend Call Working As Amag Pharmaceuti Stock Falls 29.3% (AMAG)
SmarTrend identified a Downtrend for Amag Pharmaceuti (NASDAQ:AMAG) on November 1st, 2018 at $17.89. In approximately 4 months, Amag Pharmaceuti has returned 29.29% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
70 Biggest Movers From Friday
Gainers AquaBounty Technologies, Inc. (NASDAQ: AQB) shares surged 118.3 percent to close at $4.89. AquaBounty Technologies ... 
Tags CHFS ACRX SELB
From Benzinga
50 Stocks Moving In Friday's Mid-Day Session
Gainers Stellar Biotechnologies Inc (NASDAQ: SBOT) shares jumped 105 percent to $2.46 after the company reported a share exchange ... 
Tags CALA NATR Trading Ideas
From Benzinga
AMAG Pharmaceuticals Announces Topline Results From the PROLONG Trial Evaluating Makena® (hydroxyprogesterone caproate injection)
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today topline results from PROLONG (Progestin’s Role in Optimizing Neonatal Gestation), a randomized, double-blinded, placebo-controlled clinical... 
From GlobeNewswire News Releases
Analysts Expect IJS To Hit $170
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Tonix Gets European Patent, EC Nod For Roche, Insys Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting ... 
Tags Market News SNGX NVAX
From Benzinga
AMAG Pharmaceuticals Presents New Data on Bremelanotide and Hypoactive Sexual Desire Disorder at the ISSWSH/ISSM Joint Meeting
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today that new and encore data related to bremelanotide and Hypoactive Sexual Desire Disorder (HSDD) will be presented at the upcoming International... 
From GlobeNewswire News Releases
Daily Biotech Pulse: Allergan's Depression Drug Flunks Late-Stage Trial, Apellis Offering, ShockWave Medical IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting ... 
Tags ALBO ABUS EPZM
From Benzinga
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that management will participate in the following investor conferences during the month of March: 
From GlobeNewswire News Releases
AMAG Pharmaceuticals to Present at Leerink Partners Global Healthcare Conference
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) will present at the Leerink Partners Global Healthcare Conference on Wednesday, February 27, 2019. Ted Myles, chief financial officer and Julie Krop, MD, chief... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals (AMAG) Q4 2018 Earnings Conference Call Transcript
AMAG earnings call for the period ending December 31, 2018. 
Tags Market News AMAG
From Motley Fool
16.4% Return Seen to Date on SmarTrend Amag Pharmaceuti Call (AMAG)
SmarTrend identified a Downtrend for Amag Pharmaceuti (NASDAQ:AMAG) on November 1st, 2018 at $17.89. In approximately 3 months, Amag Pharmaceuti has returned 16.38% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
AMAG Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today reported unaudited consolidated financial results for the fourth quarter and full year ended December 31, 2018, which were in-line with previously... 
From GlobeNewswire News Releases
Analysts Expect IJR To Hit $87
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Downtrend Call Working As Amag Pharmaceuti Stock Falls 15.0% (AMAG)
SmarTrend identified a Downtrend for Amag Pharmaceuti (NASDAQ:AMAG) on November 1st, 2018 at $17.89. In approximately 3 months, Amag Pharmaceuti has returned 14.98% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
AMAG Pharmaceuticals to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call and Webcast on Thursday, February 7, 2019 at 8:00 a.m. ET
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its fourth quarter and full year 2018 financial results will be released on Thursday, February 7, 2019 before the U.S. financial markets... 
From GlobeNewswire News Releases
AMAG Pharmaceuticals Completes Acquisition of Perosphere Pharmaceuticals
Adds Next Generation Small Molecule Anticoagulant Reversal Agent to Development Pipeline to Leverage AMAG’s Expertise in Hematology 
From GlobeNewswire News Releases
Research Report Identifies Edison International, MPLX LP, Moody's, AMAG Pharmaceuticals, Cross Country Healthcare, and New Mountain Finance with Renewed Outlook — Fundamental Analysis, Calculating For
From GlobeNewswire News Releases
AMAG Pharmaceuticals Appoints Christine Moulton Clemson, Ph.D., M.S.C.I. as Vice President of Medical Affairs
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of Christine Moulton Clemson, Ph.D., M.S.C.I., as vice president, medical affairs, reporting to Brian Robinson, M.D., senior... 
From GlobeNewswire News Releases
Amag Pharmaceuti Down 10.3% Since SmarTrend Downtrend Call (AMAG)
SmarTrend identified a Downtrend for Amag Pharmaceuti (NASDAQ:AMAG) on November 1st, 2018 at $17.89. In approximately 2 months, Amag Pharmaceuti has returned 10.34% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
50 51 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.